Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/03/85/bf/0385bf00-4f5f-1d37-7e70-cdfd5676802b/mza_1155440752639581066.jpeg/600x600bb.jpg
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
Christina Farr, Luba Greenwood, Ash Zenooz
39 episodes
4 months ago
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
RSS
All content for "Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD is the property of Christina Farr, Luba Greenwood, Ash Zenooz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
https://megaphone.imgix.net/podcasts/065d4ae6-0f8d-11f0-b38a-d785e32cd39f/image/67b2c4e8bf5765323df95f8c9552ff70.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress
Why 25% of Gen Z might need a different type of healthcare, with Liana Guzmán, CEO of FOLX
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
38 minutes
7 months ago
Why 25% of Gen Z might need a different type of healthcare, with Liana Guzmán, CEO of FOLX
This week on Second Opinion, Christina Farr interviews Liana Douillet Guzmán, CEO of FOLX, about the healthcare challenges faced by the LGBTQIA+ community. They discuss systemic discrimination, the growing demand for inclusive care, and the importance of patient-centered, community-based healthcare solutions tailored to the unique needs of LGBTQ+ individuals. — 📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess   🙏 Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse    — SPONSORS: 🏥 Thatch makes it easy to give your team great healthcare. Save ~$1620 per employee yearly while giving them customizable plans. Visit https://thatch.ai/HR for a demo and receive a $100 gift card. 🏋🏻‍♀️ Strengthen your cells from the inside-out with Fatty15, a pure C15 supplement proven to boost energy, improve sleep, and support metabolic, heart, and liver health – without the downsides of fish oil. Ready to restore your long-term health? Get 15% off your 90-day subscription Starter Kit at https://fatty15.com/secondopinion using code SECONDOPINION at checkout.  👩‍⚕️ Hot flashes, insomnia, brain fog? You don't have to accept these as just another part of aging. Midi Health is the virtual care clinic for women navigating midlife hormonal transition, offering FDA-approved medications, supplements and lifestyle coaching - all covered by insurance. Visit https://joinmidi.com to book your virtual visit today. — LINKS: FOLX Health: https://www.folxhealth.com/  — FOLLOW: https://www.linkedin.com/in/lianaguzman  https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/lubagreenwood/  https://www.linkedin.com/in/ashzenooz/ — HIGHLIGHTS FROM THE EPISODE: FOLX is a virtual clinic providing healthcare specifically for LGBTQIA+ individuals. The current healthcare system was not built for LGBTQIA+ individuals and is often openly discriminatory. 40% of LGBTQIA+ community avoids seeking medical care due to fear of discrimination. 10% of US adult population identifies as queer, while 25%+ of Gen Z identifies as queer. LGBTQIA+ community has higher rates of mental health challenges due to societal stress. Most clinicians graduate with only five hours of LGBTQIA+ training. FOLX started as a direct-to-consumer service for gender-affirming care and expanded to serve the broader LGBTQIA+ community. The company added insurance acceptance and employer partnerships to increase accessibility. The current political climate has created increased demand for FOLX's services. Patient-centered care should value the patient's expertise about their own experience. Liana believes "you can do good and do well at the same time." FOLX positions itself as a smart business decision rather than just a DEI initiative.
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co